Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Outcome of Patients Initiating Chronic Peritoneal Dialysis During the First Year of Life
Carey, William A., Martz, Karen, Warady, Bradley A.

Pediatrics | August 25, 2015 | Volume: 136 | Issue: 3 | Pages: e615-e622

10.1542/peds.2015-0980 | PMID 26304827 Get It

BACKGROUND AND OBJECTIVE: Among children with end-stage renal disease (ESRD), those who initiated chronic dialysis during the first year of life historically were less likely to survive or receive a kidney transplant compared with those who initiated dialysis later in childhood. We hypothesized that recently treated infants have experienced improved outcomes. METHODS: We queried the North American Pediatric Renal Trials and Collaborative Studies database, obtaining information on 628 children who initiated maintenance peritoneal dialysis for treatment of ESRD at <1 year of age. We further subcategorized these children by age (neonates, ≤31 days and infants, 32–365 days) and date of dialysis initiation (past, 1992–1999, and recent, 2000–2012). RESULTS: Survival while on dialysis and overall survival were significantly better among neonates and infants in the recent cohort. Overall survival at 3 years after dialysis initiation was 78.6% and 84.6% among the recently treated neonates and infants, respectively. Neonates and infants in the recent cohort also were more likely to terminate dialysis for transplantation, and graft survival was improved among recently transplanted infants (3-year graft survival 92.1%). CONCLUSIONS: Among children who initiate chronic peritoneal dialysis for treatment of ESRD in the first year of life, survival has improved in recent years. Graft survival also has improved for the subset of these patients who received a kidney transplant.
Non‐enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders
Grover, Madhusudan , Halder, Smita , Locke, G. Richard, Schleck, Cathy D. , Zinsmeister, Alan R., Paula, Hellen da Silva Cintra de , Talley, Nicholas J.

Neurogastroenterology & Motility | August 25, 2015 | Volume: 27 | Issue: 11 | Pages: 1580-1586

10.1111/nmo.12655 | PMID 26303310 Get It

Abstract Background Gastrointestinal infections are risk factors for irritable bowel syndrome ( IBS ) and functional dyspepsia ( FD ). We investigated whether non‐enteric infections and antibiotic exposure are also associated with the development of functional gastrointestinal disorders ( FGID s). Methods In a nested case–control study, random samples of Olmsted County, MN , were mailed valid self‐report questionnaires from 1988 through 1994, and then follow‐up questionnaires from 1995 through 2003. Survey responders who did not report any FGID symptoms at baseline, but then reported such symptoms in at least one subsequent survey, were classified as new‐onset cases. Age‐matched controls were individuals who did not have symptoms at either the initial or subsequent surveys. Key Results The overall response rate was 78% to the initial survey and 52% to the follow‐up survey. Based on the responses, 316 participants had a new onset of an FGID (43 IBS constipation, 95 IBS diarrhea, 25 IBS mixed, and 153 other FGID s, including FD ) and 250 did not (controls). Around 76% (241/316) of cases reported a non‐enteric infection vs 66% (166/250) of the controls. The frequency of enteric infections was similar between the two groups. Of the new FGID cases, 83% had a non‐enteric infection that was treated with antibiotic. In a logistic regression model, treatment with antibiotics for a non‐gastrointestinal infection was associated with the development of an FGID (odds ratio = 1.90; 95% CI : 1.21–2.98; p = 0.005), after adjusting for age and sex. Conclusions & Inferences Based on a case–control study, treatment of a non‐gastrointestinal infection with antibiotics appears to be a risk factor for development of an FGID .
Overview of palliative care and hospice services
Wordingham, Sara E., Swetz, Keith M.

Clinical Liver Disease | August 24, 2015 | Volume: 6 | Issue: 2 | Pages: 30-32

10.1002/cld.486 | PMID 31040982 Get It

Watch a video presentation of this articleWatch the interview with the author
Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy
Tillema, Jan‐Mendelt , Derks, Marloes G.M. , Pouwels, Petra J. W. , Rappard, Diane F. van, Barkhof, Frederik , Steenweg, Marjan E., Wolf, Nicole I. , Graaf, Pim de , Knaap, Marjo S. van der , Wolf, Nicole I , Barkhof, Frederik

Annals of Clinical and Translational Neurology | August 24, 2015 | Volume: 2 | Issue: 9 | Pages: 932-940

10.1002/acn3.232 | PMID 26401514 Get It

AbstractObjectiveMetachromatic leukodystrophy (MLD) is an inherited lysosomal disorder due to a deficiency in arylsulfatase A with progressive demyelination and neurological decline. This retrospective MRI study investigated the extent of cortical involvement at time of diagnosis, and clinical correlates to both conventional and regional volumetric measures of brain involvement.Methods3D‐T1‐weighted MRI scans were used to determine cortical thickness and surface‐based cerebral cortical gray matter (GM) and cerebral white matter (WM) volume (GMV and WMV), WM lesions, thalamus, and cerebellum. MRI‐MLD severity scores were obtained from FLAIR images. Associations between clinical and imaging data were examined using correlation coefficients.ResultsTwenty patients with MLD (mean age 13.7 years, range 2–35) and 20 controls (mean age 13.9 years, range 2–40) were included. Compared with control subjects, late‐infantile, and juvenile patients (n = 14) had significantly diminished cerebral cortical GMV and thalamus volume (P < 0.05), but did not differ in WMV and cortical thickness. Adult patients (n = 6) showed significantly reduced GMV, WMV and cortical thickness (all P < 0.05). Regional analysis showed statistically significant cortical thinning in the cingulate gyrus and most pronounced thinning with age in the frontal lobe of MLD patients. Intelligence quotient (IQ) correlated with MRI‐MLD scores (r = −0.87, P < 0.001).InterpretationSignificant cerebral cortical GMV loss is already present in early stages of MLD. IQ correlates with WM severity scores and lesion volume, but not with volumetric measures. In adult presentations, there is more pronounced global atrophy with GMV and WMV loss and accelerated cortical thinning, most prominently in the cingulate gyrus and frontal lobes.
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques
Monsell, Sarah E. , Kukull, Walter A. , Roher, Alex E., Maarouf, Chera L., Beach, Thomas G. , Caselli, Richard J. , Montine, Thomas J. , Reiman, Eric M. , Serrano, Geidy E.

JAMA Neurology | August 24, 2015 | Volume: 72 | Issue: 10 | Pages: 1124

10.1001/jamaneurol.2015.1721 | PMID 26302353 Get It

Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer
Watkins, Jack L., Nick, Alpa M. , Urbauer, Diana L. , Matsuo, Koji , Squires, Kathryn C., Lutgendorf, Susan K. , Ramírez, Pedro T. , Thaker, Premal H. , Ramondetta, Lois Michelle , Kumar, Sanjeev , Coleman, Robert L. , Sood, Anil K.

Cancer | August 24, 2015 | Volume: 121 | Issue: 19 | Pages: 3444-3451

10.1002/cncr.29392 | PMID 26301456 Get It

BACKGROUNDPreclinical evidence has suggested that sustained adrenergic activation can promote ovarian cancer growth and metastasis. The authors examined the impact of beta‐adrenergic blockade on the clinical outcome of women with epithelial ovarian, primary peritoneal, or fallopian tube cancers (collectively, epithelial ovarian cancer [EOC]).METHODSA multicenter review of 1425 women with histopathologically confirmed EOC was performed. Comparisons were made between patients with documented beta‐blocker use during chemotherapy and those without beta‐blocker use.RESULTSThe median age of patients in the current study was 63 years (range, 21‐93 years). The sample included 269 patients who received beta‐blockers. Of those, 193 (71.7%) were receiving beta‐1–adrenergic receptor selective agents, and the remaining patients were receiving nonselective beta antagonists. The primary indication for beta‐blocker use was hypertension but also included arrhythmia and postmyocardial infarction management. For patients receiving any beta‐blocker, the median overall survival (OS) was 47.8 months versus 42 months for nonusers (P =.04). The median OS based on beta‐blocker receptor selectivity was 94.9 months for those receiving nonselective beta‐blockers versus 38 months for those receiving beta‐1–adrenergic receptor selective agents (P<.001). Hypertension was associated with decreased OS compared with no hypertension across all groups. However, even among patients with hypertension, a longer median OS was observed among users of a nonselective beta‐blocker compared with nonusers (38.2 months vs 90 months; P<.001).CONCLUSIONSUse of nonselective beta‐blockers in patients with EOC was associated with longer OS. These findings may have implications for new therapeutic approaches. Cancer 2015;121:3435–43. © 2015 American Cancer Society.
Long‐term quality of life outcomes and retreatment rates after robotic sacrocolpopexy
Linder, Brian J. , Chow, George K. , Elliott, Daniel S. , Linder, Brian J

International Journal of Urology | August 24, 2015 | Volume: 22 | Issue: 12 | Pages: 1155-1158

10.1111/iju.12900 | PMID 26300382 Get It

ObjectiveTo evaluate the long‐term outcomes and potential predictors of treatment failure after robotic sacrocolpopexy.MethodsWe identified 70 consecutive patients from 2002 to 2012 with symptomatic post‐hysterectomy vaginal vault prolapse that underwent robotic sacrocolpopexy. Multiple clinical and surgical variables were evaluated for potential association with treatment failure, which was defined as any repeat operation for recurrent prolapse or mesh‐related complications.ResultsThe median age at surgery was 67 years (interquartile range 59–74 years) and median follow up was 72 months (interquartile range 39–114 months). Overall, six out of 70 patients (8.6%) underwent a total of six secondary surgeries, including four for recurrent prolapse (two anterior repairs, one posterior repair, one apical) and two mesh complications. No patient‐related factors were associated with the risk of repeat surgery: age (P = 0.45), diabetes mellitus (P = 0.24), tobacco use (P = 0.61) or prior prolapse surgery (P = 0.1) on univariate analysis. Freedom from repeat prolapse surgery or surgery for mesh complication was 98% at 1 year, 95% at 3 years and 90% at 6 years. At last follow up, 80% of patients reported that they would or probably would recommend robotic sacrocolpopexy to a family member or friend.ConclusionsRobotic sacrocolpopexy is associated with excellent long‐term outcomes. Recognition of long‐term success is important for preoperative patient counseling.
Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils
Marin‐Argany, Marta , Güell‐Bosch, Jofre, Blancas‐Mejía, Luis M. , Villegas, Sandra , Ramı́rez-Alvarado, Marina , Ramirez-Alvarado, Marina

Protein Science | August 24, 2015 | Volume: 24 | Issue: 11 | Pages: 1829-1840

10.1002/pro.2790 | PMID 26300552 Get It

AbstractLight chain (AL) amyloidosis is an incurable human disease, where the amyloid precursor is a misfolding‐prone immunoglobulin light‐chain. Here, we identify the role of somatic mutations in the structure, stability and in vitro fibril formation for an amyloidogenic AL‐12 protein by restoring four nonconservative mutations to their germline (wild‐type) sequence. The single restorative mutations do not affect significantly the native structure, the unfolding pathway, and the reversibility of the protein. However, certain mutations either decrease (H32Y and H70D) or increase (R65S and Q96Y) the protein thermal stability. Interestingly, the most and the least stable mutants, Q96Y and H32Y, do not form amyloid fibrils under physiological conditions. Thus, Q96 and H32 are key residues for AL‐12 stability and fibril formation and restoring them to the wild‐type residues preclude amyloid formation. The mutants whose equilibrium is shifted to either the native or unfolded states barely sample transient partially folded states, and therefore do not form fibrils. These results agree with previous observations by our laboratory and others that amyloid formation occurs because of the sampling of partially folded states found within the unfolding transition (Blancas‐Mejia and Ramirez‐Alvarado, Ann Rev Biochem 2013;82:745–774). Here we provide a new insight on the AL amyloidosis mechanism by demonstrating that AL‐12 does not follow the established thermodynamic hypothesis of amyloid formation. In this hypothesis, thermodynamically unstable proteins are more prone to amyloid formation. Here we show that within a thermal stability range, the most stable protein in this study is the most amyloidogenic protein.
Upper Gastrointestinal Bleeding from Gastric Amyloidosis in a Patient with Smoldering Multiple Myeloma
Gjeorgjievski, Mihajlo , Purohit, Treta , Amin, Mitual , Kurtin, Paul J. , Cappell, Mitchell S.

Case Reports in Gastrointestinal Medicine | August 23, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-6

10.1155/2015/320120 | PMID 26366309 Get It

Amyloidosis is a common complication of patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and multiple myeloma (MM). This proteinaceous material can be deposited intercellularly in any organ system, including the gastrointestinal (GI) tract. In the GI tract, amyloidosis affects the duodenum most commonly, followed by the stomach and colorectum. Gastric amyloidosis causes symptoms of nausea, vomiting, early satiety, abdominal pain, and GI bleeding. A case of upper GI bleeding from gastric amyloidosis is presented in a patient with SMM. Esophagogastroduodenoscopy (EGD) revealed a gastric mass. Endoscopic biopsies revealed amyloid deposition in the lamina propria, consistent with gastric amyloidosis. Liquid chromatography tandem mass spectrometry performed on peptides extracted from Congo red-positive microdissected areas of paraffin-embedded stomach specimens revealed a peptide profile consistent with AL- (lambda-) type amyloidosis. Based on this and multiple other case reports, we recommend that patients with GI bleeding and MGUS, SMM, or MM undergo EGD and pathologic examination of endoscopic biopsies of identified lesions using Congo red stains for amyloidosis for early diagnosis and treatment.
Aberrant Gene Regulation in Obstetric, Gynecologic, and Reproductive Diseases
Jiang, Shi‐Wen , Brost, Brian , Zhang, Dan , Ren, Chune

BioMed Research International | August 23, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-2

10.1155/2015/187691 | PMID 26366409 Get It